NMC Health plc

NMC Health plc

NMMCF
NMC Health plcUS flagOther OTC
0.00
USD
- -
- -
2,087.00Market Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
Revenue per Share
1.66
1.89
3.41
2.85
2.97
3.47
4.74
6.54
7.85
9.9
Basic EPS, GAAP
0.04
0.1
0.33
0.34
0.37
0.41
0.44
0.71
0.91
1.2
Free Cash Flow per Basic Share
0.11
0.03
0.39
-0.41
0.03
-0.14
0.02
0.62
1.04
1.07
Dividend per Share
- -
- -
- -
- -
0.06
0.07
0.09
0.09
0.14
0.17
Book Value per Share
0.16
0.24
0.76
0.93
1.17
1.51
1.87
2.51
3.11
3.17
Tangible Book Value per Share
0.44
0.5
0.77
1.92
2.08
2.42
0.47
1.59
-0.06
-1.26
Basic Weighted Avg Shares
204
204
130
172
186
186
186
187
204
208
Sales/Revenue/Turnover
339
387
444
490
551
644
881
1,221
1,603
2,057
Operating Margin (%)
0.12
6.43
13.16
14.81
15.12
13.73
13.06
15.57
17.62
18.81
Depreciation Expense
15
14
12
7
10
14
35
56
71
100
Net Income, GAAP
8
21
43
59
68
77
82
133
186
249
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
0.11
0.59
1.92
Profit Margin (%)
2.25
5.46
9.69
12.02
12.37
11.89
9.33
10.87
11.6
12.09
Working Capital
-7
-34
50
257
287
207
202
488
425
431
LT Debt
67
20
35
118
162
114
484
595
988
1,447
Total Equity
91
103
100
332
389
453
500
949
1,145
1,357
Return on Invested Capital (%)
- -
7.75
19.09
16.02
12.41
11.53
- -
11.85
12.43
12.96
Return on Capital (%)
- -
13.43
20.27
18.7
15.7
14.5
- -
10.99
11.82
14.8
Return on Common Equity (%)
- -
51.63
57.64
45.33
36.1
30.81
26.2
32.53
33.71
38.44

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
31.15%
18.53%
Free Cash Flow
- -
423.38%
4.79%
Net Income, GAAP
- -
30.99%
33.71%
Sales/Revenue/Turnover
- -
30.39%
28.31%
Total Cash Common Dividend
- -
27.11%
28.65%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
1,603
2018
- -
- -
- -
- -
2,057
2019
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
0.91
2018
- -
- -
- -
- -
1.2
2019
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
0.14
2018
- -
- -
- -
- -
0.17
2019
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
David J. Hadley
Full Time Employees
17,748
Sector
Healthcare
Industry
Medical - Care Facilities
Address
Devonshire House London United Kingdom W1J 8AJ
IPO Date
May 22, 2018
Website
nmc.ae
Business
NMC Health plc (Ticker: NMMCF) operates as a diversified healthcare provider primarily through its subsidiary NMC Healthcare, one of the largest private healthcare networks in the United Arab Emirates; the company delivers comprehensive multi-specialty medical services including hospitals, medical centers, long-term care facilities, day surgery centers, fertility clinics, home health services, outpatient and inpatient diagnostics, gynecology, obstetrics, pediatrics, orthopedics, physiotherapy, urology, neurosurgery, family medicine, intensive care, endocrinology, radiology, primary care, wellness programs, weight management, emergency care, and maternity services across approximately 70 to 85 facilities serving over 5.5 million patients annually in Abu Dhabi, Dubai, Sharjah, and the Northern Emirates such as Ras Al Khaimah and Ajman; additionally, NMC Trading distributes pharmaceuticals, medical equipment, scientific instruments, veterinary products, fast-moving consumer goods, and brands including Pfizer, Sanofi, Siemens, Nestlé, Unilever, Abbott, and Medtronic. Founded in 1975 and headquartered in Abu Dhabi, United Arab Emirates, the company maintains operations focused on the UAE market with historic expansions into regions like Saudi Arabia, Spain, the United Kingdom, and Oman. In recent developments, NMC Healthcare implements a four-pillar growth strategy encompassing portfolio expansion through the acquisition of Orthoplus Bone Centre in Al Ain and launches of new facilities such as Marina Walk paediatric center, Nakheel Mall Palm Jumeirah multi-specialty center, and expansions at NMC Royal Hospital Khalifa City; asset optimization via major 2025 renovations at Dubai Investment Park into a 220-bed hospital with trauma and women/children units and at Al Nahda Hospital including a new connecting bridge; operational enhancements through partnerships like Snowflake for AI-powered data analytics; service line growth with new primary care initiatives and a transplant center at NMC Royal Hospital Sharjah; achievement of enterprise-wide Joint Commission International accreditation; divestment of its 65% stake in Fakih IVF to Blue Ocean Health Group to fund core expansions; and ongoing exploration of acquisition by PureHealth amid post-2020 restructuring ownership by creditors.